
levidex is designed to offer therapeutic techniques and exercises based on evidence-based psychological-psychotherapeutic treatment methods, suitable for patients with Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS), to support them in managing their MS or CIS. It is for independent use as part of usual care for patients aged 18+. It is not intended to replace provider treatments or provide diagnostic/therapeutic decision info. Indications: Multiple sclerosis [encephalomyelitis disseminata] (G35).
Pricing
Paid
Manufacturer price €247.81 per prescription (90 days). DiGA directory: https://diga.bfarm.de/en/verzeichnis/00752
Category
Digital Therapeutics
Tags
—
Added
Sep 2026
Conditions (ICD-10)
Categories
Pros
- Permanently listed in the German BfArM DiGA directory
- Prescribable and reimbursed by German statutory health insurance
- Therapeutic area: Nervous System